Michael Lourenco Costa - Feb 28, 2023 Form 4 Insider Report for Sabra Health Care REIT, Inc. (SBRA)

Signature
/s/ Michael Lourenco Costa
Stock symbol
SBRA
Transactions as of
Feb 28, 2023
Transactions value $
-$60,782
Form type
4
Date filed
3/2/2023, 06:05 PM
Previous filing
Jan 31, 2023
Next filing
Jun 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SBRA Common Stock Award $0 +1.94K +1.17% $0.00 167K Feb 28, 2023 Direct F1
transaction SBRA Common Stock Award $0 +14.9K +8.89% $0.00 182K Mar 1, 2023 Direct F2
transaction SBRA Common Stock Tax liability -$60.8K -5.15K -2.82% $11.80 177K Mar 1, 2023 Direct F3, F4
holding SBRA Common Stock 784 Feb 28, 2023 By Reporting Person's IRA
holding SBRA Common Stock 208 Feb 28, 2023 By Reporting Person's Spouse's IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
F2 Represents shares of the Issuer's Common Stock issued under the Issuer's 2009 Performance Incentive Plan subject to an annual bonus performance stock unit ("PSU") award granted on August 10, 2022, including 1,357 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on March 1, 2023 that the number of PSUs earned was 115.2% of the target. Upon this determination, the PSUs vested and were paid out immediately. Each PSU represented a contingent right to receive one share of the Issuer's Common Stock, based on the Issuer's achievement of an adjusted normalized funds from operations per share target for a performance period beginning January 1, 2022 and ending December 31, 2022.
F3 Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.
F4 Includes 78,967 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.